RLAY R&D Expenses

Relay Therapeutics Inc · R&D Expenses

RLAY logo

RLAY R&D Expenses

Latest reported$76.48M
RLAY Quarterly R&D Expenses ($13.34M → $76.48M)
High-resolution chart · PNG

RLAY r&d expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Relay Therapeutics Inc R&D Expenses — Quarterly (USD)
Period endingR&D Expenses (USD)
76,483,000
70,563,000
55,415,000
68,262,000
63,897,000
73,809,000
68,075,000
76,619,000
91,992,000
82,403,000
77,496,000
81,494,000
88,201,000
82,827,000
67,277,000
66,900,000
60,511,000
51,667,000
51,907,000
44,974,000
168,147,000
30,622,000
31,415,000
24,376,000
21,666,000
21,700,000
22,407,000
18,256,000
16,397,000
13,335,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.